Jump to content

Azithromycin

From Simple English Wikipedia, the free encyclopedia
The structure of azithromycin

Azithromycin is an antibiotic which is used to treat a number of different bacterial infections in humans, such as strep throat, pneumonia, and bronchitis.[1] It was discovered in the late 1970s in Yugoslavia and is still one of the most popular antibiotics in the world.[2][3] Azithromycin kills bacteria by stopping it from making proteins.[1]

The packaging of the Sumamed sold by Pliva

Azithromycin was discovered by a team of scientists working in the Research Institute of the pharmaceutical company Pliva in late 1970s Croatia.[4]

Pliva and the drug company Pfizer agreed that azithromycin could be used worldwide. Pliva sold azithromycin in Central and Eastern Europe under the name Sumamed, becoming one of the biggest pharmaceutical companies in those regions.[2] Pfizer patented the drug in 1981 and sold it under the name Zithromax,[5] which brought the company great commercial success. In Zithromax's best-selling year, Pfizer earned $2 billion from sales of the drug.[2]

Use in medicine

[change | change source]

Azithromycin is usually prescribed in the form of tablets.[5] The drug targets the ribosome of the bacteria, where proteins are made. This prevents mRNA from getting turned into proteins. Because they can no longer make proteins, the bacteria die and the infection ends.[6]

Effectiveness

[change | change source]

Azithromycin is particularly effective against certain bacteria, some of which cannot be killed with other antibiotics.[5] For example, a form of Staphylococcus aureus called MRSA is resistant to all penicillins (like amoxicillin) and all cephalosporin antibiotics (like Keflex), but it responds well to azithromycin.[7]

Life-threatening infections

[change | change source]

Azithromycin is an effective treatment for several life-threatening bacterial infections of the lungs (called pneumonia); the blood (called sepsis); the heart valves (endocarditis); the bones (osteomyelitis); and/or the lining of the brain and spinal cord (meningitis). It can also treat toxic shock syndrome and an aggressive flesh-eating bacterial infection called necrotizing fasciitis.[8]

When these infections are caused by bacteria like Staphylococcus aureus[9], Streptococcus pneumoniae[10], Streptococcus agalactiae[11], Haemophilus influenzae[12], and Streptococcus pyogenes[13], azithromycin can often kill the bacteria and end the infection.

Sexually transmitted infections

[change | change source]

Azithromycin works well to treat several sexually transmitted infections. These include gonorrhea, which is caused by Neisseria gonorrhoeae). If untreated, it can cause blindness in newborns, infertility in both men and women, pelvic inflammatory disease, and ectopic pregnancy (where an embryo implants itself outside of the uterus).[14]

Azithromycin can also treat chlamydia (caused by Chlamydia trachomatis), which can cause various infections of the urinary and genital systems.

Azithromycin is also an effective treatment for chancroid (caused by Haemophilus ducreyi[15]), a common cause of genital ulcers in impoverished parts of Asia, Africa, and the Caribbean.[16] Chancroid (and other diseases that cause genital ulcers) raise a person's risk of getting infected with HIV.[16]

Other infections

[change | change source]

Azithromycin works well to kill various other bacteria, including:

Use during COVID-19 pandemic

[change | change source]

Azithromycin was widely used during the COVID-19 pandemic to treat coronavirus patients. However, research found that the drug is ineffective and even increases the chances of hospitalisation.[20][21]

Side effects

[change | change source]

Common side effects when taking azithromycin include feeling sick, diarrhoea, vomiting, losing your appetite, headaches, feeling dizzy or tired, changes to your sense of taste.[22] Serious but rare side effects include liver damage, heart rhythm changes, and serious allergic reactions.[23]

References

[change | change source]
  1. 1.0 1.1 Bakheit, Ahmed H. H.; Al-Hadiya, Badraddin M. H.; Abd-Elgalil, Ahmed A. (1 January 2014). "Chapter One - Azithromycin". Profiles of Drug Substances, Excipients and Related Methodology. Academic Press. pp. 1–40.
  2. 2.0 2.1 2.2 "Azithromycin: A world best-selling Antibiotic".
  3. "The Top 300 of 2020". clincalc.com.
  4. Banić Tomišić, Z. (2011-12-01). "The Story of Azithromycin" (PDF). Kemija u Industriji. 60 (12): 603–617. ISSN 0022-9830. Archived from the original (PDF) on 2017-12-02. Retrieved 2023-07-20.
  5. 5.0 5.1 5.2 "Azithromycin".
  6. Heidary, Mohsen; Ebrahimi Samangani, Ahmad; Kargari, Abolfazl; Kiani Nejad, Aliakbar; Yashmi, Ilya; Motahar, Moloudsadat; Taki, Elahe; Khoshnood, Saeed (June 2022). "Mechanism of action, resistance, synergism, and clinical implications of azithromycin". Journal of Clinical Laboratory Analysis. 36 (6). doi:10.1002/jcla.24427.
  7. "About MRSA - MN Dept. of Health". www.health.state.mn.us. Retrieved 2024-09-20.
  8. Stevens, Dennis L.; Bryant, Amy E. (2016), Ferretti, Joseph J.; Stevens, Dennis L.; Fischetti, Vincent A. (eds.), "Severe Group A Streptococcal Infections", Streptococcus pyogenes: Basic Biology to Clinical Manifestations, Oklahoma City (OK): University of Oklahoma Health Sciences Center, PMID 26866227, retrieved 2024-09-20
  9. Taylor, Tracey A.; Unakal, Chandrashekhar G. (2024), "Staphylococcus aureus Infection", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722898, retrieved 2024-09-20
  10. CDC (2024-06-21). "About Pneumococcal Disease". Pneumococcal Disease. Retrieved 2024-09-20.
  11. "Group B Streptococcus (GBS) Infections: Practice Essentials, Background, Pathophysiology". Medscape. 2024-05-06.
  12. "Factsheet about Invasive Haemophilus influenzae disease". www.ecdc.europa.eu. 2017-02-22. Retrieved 2024-09-20.
  13. Kanwal, Sidrah; Vaitla, Pradeep (2024), "Streptococcus Pyogenes", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32119415, retrieved 2024-09-20
  14. "Gonorrhoea (Neisseria gonorrhoeae infection)". www.who.int. Retrieved 2024-09-20.
  15. "Chancroid". dph.illinois.gov. Retrieved 2024-09-20.
  16. 16.0 16.1 "Chancroid - Chancroid". Merck Manual Professional Edition. Retrieved 2024-09-20.
  17. "Helicobacter Pylori". dph.illinois.gov. Retrieved 2024-09-20.
  18. "Moraxella catarrhalis Infection: Background, Pathophysiology and Etiology, Epidemiology". Medscape. 2023-06-18.
  19. CDC (2024-08-28). "About Mycoplasma pneumoniae Infection". Mycoplasma pneumoniae Infection. Retrieved 2024-09-20.
  20. "Common COVID-19 Antibiotic No More Effective Than Placebo | UC San Francisco". www.ucsf.edu. 2021-07-16. Retrieved 2023-07-01.
  21. Beeston, Amelia (2022-05-31). "Platform trial rules out treatments for COVID-19". NIHR Evidence. Retrieved 2023-07-01.
  22. "Side effects of azithromycin". nhs.uk. 2022-01-21. Retrieved 2023-07-01.
  23. "Azithromycin: Uses, dosage, side effects, and warnings". www.medicalnewstoday.com. 2019-07-12. Retrieved 2023-07-01.